IL-17A-mediated protection against acanthamoeba keratitis

Journal of Immunology

Volumn 194, Issue 2, 2015, Pages 650-663

  Suryawanshi, Amol ^a,b   Cao, Zhiyi ^a,b   Sampson, James F ^a,b   Panjwani, Noorjahan ^a,b  

^a NEW ENGLAND EYE CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; IL17A PROTEIN, MOUSE;

ACANTHAMOEBA KERATITIS; ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; HOST RESISTANCE; INFECTION SENSITIVITY; INFLAMMATORY CELL; INNATE IMMUNITY; LYMPHATIC DRAINAGE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; ACANTHAMOEBA; ANIMAL; CELLULAR IMMUNITY; CORNEA; DISEASE MODEL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPH NODE; PARASITOLOGY; PATHOLOGY;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ANIMALS; CORNEA; DISEASE MODELS, ANIMAL; FEMALE; IMMUNITY, CELLULAR; INTERLEUKIN-17; LYMPH NODES; MICE; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84920495667     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302707     Document Type: Article

References (69)

1. Lorenzo-Morales, J., C. M. Martín-Navarro, A. López-Arencibia, F. Arnalich- Montiel, J. E. Piñero, and B. Valladares. 2013. Acanthamoeba keratitis: An emerging disease gathering importance worldwide? Trends Parasitol. 29: 181-187.
2. Panjwani, N. 2010. Pathogenesis of acanthamoeba keratitis. Ocul. Surf. 8: 70-79.
3. Marciano-Cabral, F., and G. Cabral. 2003. Acanthamoeba spp. as agents of disease in humans. Clin. Microbiol. Rev. 16: 273-307.
4. Clarke, D. W., and J. Y. Niederkorn. 2006. The pathophysiology of Acanthamoeba keratitis. Trends Parasitol. 22: 175-180.
5. Hammersmith, K. M. 2006. Diagnosis and management of Acanthamoeba keratitis. Curr. Opin. Ophthalmol. 17: 327-331.
6. Mathers, W. D. 2004. Acanthamoeba: A difficult pathogen to evaluate and treat. Cornea 23: 325.
7. Cohen, E. J., J. C. Fulton, C. J. Hoffman, C. J. Rapuano, and P. R. Laibson. 1996. Trends in contact lens-associated corneal ulcers. Cornea 15: 566-570.
8. Seal, D. V. 2003. Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Eye (Lond.) 17: 893-905.
9. Stehr-Green, J. K., T. M. Bailey, and G. S. Visvesvara. 1989. The epidemiology of Acanthamoeba keratitis in the United States. Am. J. Ophthalmol. 107: 331-336.
10. Demirci, G., G. M. Ay, L. V. Karabas, O. Altintas, G. S. Tamer, and Y. Caglar. 2006. Acanthamoeba keratitis in a 5-year-old boy without a history of contact lens usage. Cornea 25: 356-358.
11. Illingworth, C. D., S. D. Cook, C. H. Karabatsas, and D. L. Easty. 1995. Acanthamoeba keratitis: risk factors and outcome. Br. J. Ophthalmol. 79: 1078-1082.
12. Sharma, S., M. Srinivasan, and C. George. 1990. Acanthamoeba keratitis in noncontact lens wearers. Arch. Ophthalmol. 108: 676-678.
13. Srinivasan, M., S. Burman, C. George, and P. K. Nirmalan. 2003. Non-contact lens related Acanthamoeba keratitis at a tertiary eye care center in south India: Implications for eye care programs in the region. Med. Sci. Monit. 9: CR125-CR129.
14. Clarke, D. W., and J. Y. Niederkorn. 2006. The immunobiology of Acanthamoeba keratitis. Microbes Infect. 8: 1400-1405.
15. Niederkorn, J. Y. 2002. The role of the innate and adaptive immune responses in Acanthamoeba keratitis. Arch. Immunol. Ther. Exp. (Warsz.) 50: 53-59.
16. Niederkorn, J. Y., H. Alizadeh, H. F. Leher, and J. P. McCulley. 1999. The immunobiology of Acanthamoeba keratitis. Springer Semin. Immunopathol. 21: 147-160.
17. Van Klink, F., H. Leher, M. J. Jager, H. Alizadeh, W. Taylor, and J. Y. Niederkorn. 1997. Systemic immune response to Acanthamoeba keratitis in the Chinese hamster. Ocul. Immunol. Inflamm. 5: 235-244.
18. He, Y. G., J. P. McCulley, H. Alizadeh, M. Pidherney, J. Mellon, J. E. Ubelaker, G. L. Stewart, R. E. Silvany, and J. Y. Niederkorn. 1992. A pig model of Acanthamoeba keratitis: Transmission via contaminated contact lenses. Invest. Ophthalmol. Vis. Sci. 33: 126-133.
19. van Klink, F., W. M. Taylor, H. Alizadeh, M. J. Jager, N. van Rooijen, and J. Y. Niederkorn. 1996. The role of macrophages in Acanthamoeba keratitis. Invest. Ophthalmol. Vis. Sci. 37: 1271-1281.
20. Hurt, M., S. Apte, H. Leher, K. Howard, J. Niederkorn, and H. Alizadeh. 2001. Exacerbation of Acanthamoeba keratitis in animals treated with anti-macrophage inflammatory protein 2 or antineutrophil antibodies. Infect. Immun. 69: 2988- 2995.
21. McCulley, J. P., H. Alizadeh, and J. Y. Niederkorn. 1995. Acanthamoeba keratitis. CLAO J. 21: 73-76.
22. Knickelbein, J. E., J. Kovarik, D. K. Dhaliwal, and C. T. Chu. 2013. Acanthamoeba keratitis: A clinicopathologic case report and review of the literature. Hum. Pathol. 44: 918-922.
23. Mathers, W., G. Stevens Jr., M. Rodrigues, C. C. Chan, J. Gold, G. S. Visvesvara, M. A. Lemp, and L. E. Zimmerman. 1987. Immunopathology and electron microscopy of Acanthamoeba keratitis. Am. J. Ophthalmol. 103: 626-635.
24. Larkin, D. F., and D. L. Easty. 1991. Experimental Acanthamoeba keratitis: II. Immunohistochemical evaluation. Br. J. Ophthalmol. 75: 421-424.
25. Iwakura, Y., H. Ishigame, S. Saijo, and S. Nakae. 2011. Functional specialization of interleukin-17 family members. Immunity 34: 149-162.
26. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27: 485-517.
27. Reynolds, J. M., P. Angkasekwinai, and C. Dong. 2010. IL-17 family member cytokines: regulation and function in innate immunity. Cytokine Growth Factor Rev. 21: 413-423.
28. Shen, F., and S. L. Gaffen. 2008. Structure-function relationships in the IL-17 receptor: Implications for signal transduction and therapy. Cytokine 41: 92-104.
29. Suryawanshi, A., T. Veiga-Parga, N. K. Rajasagi, P. B. Reddy, S. Sehrawat, S. Sharma, and B. T. Rouse. 2011. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J. Immunol. 187: 1919-1930.
30. uryawanshi, A., T. Veiga-Parga, P. B. Reddy, N. K. Rajasagi, and B. T. Rouse. 2012. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J. Immunol. 188: 3434-3446.
31. Suryawanshi, A., S. Mulik, S. Sharma, P. B. Reddy, S. Sehrawat, and B. T. Rouse. 2011. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J. Immunol. 186: 3653-3665.
32. Suryawanshi, A., Z. Cao, T. Thitiprasert, T. S. Zaidi, and N. Panjwani. 2013. Galectin-1-mediated suppression of Pseudomonas aeruginosa-induced corneal immunopathology. J. Immunol. 190: 6397-6409.
33. Hernández-Santos, N., and S. L. Gaffen. 2012. Th17 cells in immunity to Candida albicans. Cell Host Microbe 11: 425-435.
34. Liu, J., Y. Feng, K. Yang, Q. Li, L. Ye, L. Han, and H. Wan. 2011. Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice. FEMS Immunol. Med. Microbiol. 61: 179-188.
35. Miyazaki, Y., S. Hamano, S. Wang, Y. Shimanoe, Y. Iwakura, and H. Yoshida. 2010. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. J. Immunol. 185: 1150-1157.
36. Ye, P., P. B. Garvey, P. Zhang, S. Nelson, G. Bagby, W. R. Summer, P. Schwarzenberger, J. E. Shellito, and J. K. Kolls. 2001. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25: 335-340.
37. Taylor, P. R., S. M. Leal Jr., Y. Sun, and E. Pearlman. 2014. Aspergillus and Fusarium corneal infections are regulated by Th17 cells and IL-17-producing neutrophils. J. Immunol. 192: 3319-3327.
38. Taylor, P. R., S. Roy, S. M. Leal Jr., Y. Sun, S. J. Howell, B. A. Cobb, X. Li, and E. Pearlman. 2014. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgt and dectin-2. Nat. Immunol. 15: 143-151.
39. Jensen, T., W. G. Barnes, and D. Meyers. 1970. Axenic cultivation of large populations of Acanthamoeba castellanii (JBM). J. Parasitol. 56: 904-906.
40. Tarabishy, A. B., B. Aldabagh, Y. Sun, Y. Imamura, P. K. Mukherjee, J. H. Lass, M. A. Ghannoum, and E. Pearlman. 2008. MyD88 regulation of Fusarium keratitis is dependent on TLR4 and IL-1R1 but not TLR2. J. Immunol. 181: 593- 600.
41. Berk, R. S., L. D. Hazlett, and K. W. Beisel. 1987. Genetic studies on resistant and susceptibility genes controlling the mouse cornea to infection with Pseudomonas aeruginosa. Antibiot. Chemother. (1971) 39: 83-91.
42. Peng, Z., R. Omaruddin, and E. Bateman. 2005. Stable transfection of Acanthamoeba castellanii. Biochim. Biophys. Acta 1743: 93-100.
43. Siddiqui, R., and N. A. Khan. 2012. Biology and pathogenesis of Acanthamoeba. Parasit. Vectors 5: 6.
44. Hazlett, L. D. 2004. Corneal response to Pseudomonas aeruginosa infection. Prog. Retin. Eye Res. 23: 1-30.
45. Gimenez, F., A. Suryawanshi, and B. T. Rouse. 2013. Pathogenesis of herpes stromal keratitis-a focus on corneal neovascularization. Prog. Retin. Eye Res. 33: 1-9.
46. Josefowicz, S. Z., L. F. Lu, and A. Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30: 531-564.
47. Wing, K., and S. Sakaguchi. 2010. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11: 7-13.
48. Sakaguchi, S., K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi. 2009. Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21: 1105-1111.
49. J Reddy, P. B., T. H. Schreiber, N. K. Rajasagi, A. Suryawanshi, S. Mulik, T. Veiga-Parga, T. Niki, M. Hirashima, E. R. Podack, and B. T. Rouse. 2012. TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions. J. Virol. 86: 10606-10620.
50. Sehrawat, S., A. Suryawanshi, M. Hirashima, and B. T. Rouse. 2009. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: Shifting the balance toward regulators. J. Immunol. 182: 3191-3201.
51. Veiga-Parga, T., A. Suryawanshi, and B. T. Rouse. 2011. Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling. PLoS Pathog. 7: e1002427.
52. Hernández-Santos, N., A. R. Huppler, A. C. Peterson, S. A. Khader, K. C. McKenna, and S. L. Gaffen. 2013. Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol. 6: 900-910.
53. McGeachy, M. J., and S. J. McSorley. 2012. Microbial-induced Th17: Superhero or supervillain? J. Immunol. 189: 3285-3291.
54. Zaidi, T. S., T. Zaidi, G. B. Pier, and G. P. Priebe. 2012. Topical neutralization of interleukin-17 during experimental Pseudomonas aeruginosa corneal infection promotes bacterial clearance and reduces pathology. Infect. Immun. 80: 3706- 3712.
55. Pearlman, E., Y. Sun, S. Roy, M. Karmakar, A. G. Hise, L. Szczotka-Flynn, M. Ghannoum, H. R. Chinnery, P. G. McMenamin, and A. Rietsch. 2013. Host defense at the ocular surface. Int. Rev. Immunol. 32: 4-18.
56. Ren, M., and X. Wu. 2010. Evaluation of three different methods to establish animal models of Acanthamoeba keratitis. Yonsei Med. J. 51: 121-127.
57. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
58. Zhang, Q., I. Atsuta, S. Liu, C. Chen, S. Shi, S. Shi, and A. D. Le. 2013. IL-17- mediated M1/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws. Clin. Cancer Res. 19: 3176- 3188.
59. O'Connor, W. Jr., M. Kamanaka, C. J. Booth, T. Town, S. Nakae, Y. Iwakura, J. K. Kolls, and R. A. Flavell. 2009. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10: 603-609.
60. Tosello Boari, J., M. C. Amezcua Vesely, D. A. Bermejo, M. C. Ramello, C. L. Montes, H. Cejas, A. Gruppi, and E. V. Acosta Rodríguez. 2012. IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils. PLoS Pathog. 8: e1002658.
61. Clarke, B., A. Sinha, D. N. Parmar, and E. Sykakis. 2012. Advances in the diagnosis and treatment of acanthamoeba keratitis. J. Ophthalmol. 2012: 484892.
62. Wanachiwanawin, D., W. Booranapong, and P. Kosrirukvongs. 2012. Clinical features of Acanthamoeba keratitis in contact lens wearers and non-wearers. Southeast Asian J. Trop. Med. Public Health 43: 549-556.
63. Iovieno, A., R. A. Oechsler, D. R. Ledee, D. Miller, and E. C. Alfonso. 2010. Drug-resistant severe Acanthamoeba keratitis caused by rare T5 Acanthamoeba genotype. Eye Contact Lens 36: 183-184.
64. Ebrahimi, K. B., W. R. Green, R. Grebe, and A. S. Jun. 2009. Acanthamoeba sclerokeratitis. Graefes Arch. Clin. Exp. Ophthalmol. 247: 283-286.
65. Awwad, S. T., M. Heilman, R. N. Hogan, D. N. Parmar, W. M. Petroll, J. P. McCulley, and H. D. Cavanagh. 2007. Severe reactive ischemic posterior segment inflammation in acanthamoeba keratitis: A new potentially blinding syndrome. Ophthalmology 114: 313-320.
66. Hargrave, S. L., J. P. McCulley, and Z. Husseini, Brolene Study Group. 1999. Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Ophthalmology 106: 952-957.
67. Khan, N. A. 2006. Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol. Rev. 30: 564-595.
68. Parmar, D. N., S. T. Awwad, W. M. Petroll, R. W. Bowman, J. P. McCulley, and H. D. Cavanagh. 2006. Tandem scanning confocal corneal microscopy in the diagnosis of suspected acanthamoeba keratitis. Ophthalmology 113: 538-547.
69. Awwad, S. T., W. M. Petroll, J. P. McCulley, and H. D. Cavanagh. 2007. Updates in Acanthamoeba keratitis. Eye Contact Lens 33: 1-8.